Due to the more health-conscious global population, there has been a surge in demand for different healthcare products and pharmaceutical formulations in recent days. The pharmaceutical industry, both large and small, has been increasingly innovating to include healthy drugs and goods to meet this global demand. The susceptibility of certain medication ingredients or medical instruments to oxygen when in storage or transport has become a problem for the industry.
The effectiveness and shelf-life of healthcare products can be severely harmed by exposure to oxygen. It may also lead to the manufacture of harmful by-products that endanger patient welfare. Although several intrinsic and extrinsic approaches to providing a consistent low-oxygen packaging environment have been established, not all are feasible or reliable.
According to our experience, oxygen absorbers are the simplest and most cost-effective approach to this issue, and we discuss Cilicant’s excellent oxygen absorbers for healthcare products in this blog post.
Oxidative degradation in pharmaceutical packaging
Plastics and polymers are used to make the majority of packaging options for new pharmaceutical drugs. Polymer-based packaging systems have been the default option for many medications and medicinal devices due to low manufacturing costs and general ease of transportation.
Adoption of Cilicant oxygen absorbers to regulate oxygen permeation
Cilicant has dedicated a significant amount of money to the study and production of the right oxygen absorbers for medicinal drugs since its inception. Cilicant oxygen absorber sachets for pharmaceuticals are the direct result of this endeavor, and they’re designed to work with a wide variety of formulations and packaging solutions. Cilicant oxygen absorber sachets stand up to rigorous lab tests and have class-leading results in handling both atmospheric and permeating oxygen.
What can oxygen absorbers be used in?
Oxygen absorbers may be used to protect a wide range of medications from oxidation. The safety of the drug atorvastatin from oxidative degradation is a clear example of this. Atorvastatin is a common pharmaceutical that lowers LDL cholesterol while simultaneously raising HDL cholesterol levels in the bloodstream. Since atorvastatin’s solid dosage form is highly susceptible to oxidative degradation, it must be packaged in an oxygen-free setting.
Cilicant: The major product of oxygen absorbers
Cilicant oxygen absorber sachets are packaged in Generally Regarded as Safe (GRAS) materials to avoid direct contact with the pharmaceutical formulation. Cilicant oxygen absorbers, whether used in airtight or hermetically sealed tubes, offer industry-leading protection against oxidative degradation of drugs. Cilicant oxygen absorbers may also be used to prolong the shelf life of high-quality packaging films with a low OTR.